Climopax and breast cancer metastatic Patient Reports February 09, 2012

Climopax Side Effects Report #5226242-3
Climopax side effect was reported by a Consumer or non-health professional from GERMANY on Jan 15, 2007. Female patient, 67 years of age, was diagnosed with menopausal symptoms and was treated with Climopax. After drug was administered, patient experienced the following side effects: breast cancer metastatic. Climopax dosage: 0.625 MG/2.5 MG; ORAL. Patient recovered.